JF
RIGL icon

Jump Financial’s Rigel Pharmaceuticals RIGL Stock Holding History

Jump Financial’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Buy
+6,100
New +$188K ﹤0.01% 1769
2025
Q3 		– Sell
-23,022
Closed -$431K – 2159
2025
Q2 		$431K Buy
+23,022
New +$436K ﹤0.01% 1290
2025
Q1 		– Sell
-30,035
Closed -$505K – 1954
2024
Q4 		$505K Buy
30,035
+14,750
+96% +$283K 0.01% 1069
2024
Q3 		$247K Buy
+15,285
New +$180K 0.01% 1384
2022
Q4 		– Sell
-11,494
Closed -$136K – 1964
2022
Q3 		$136K Buy
+11,494
New +$155K 0.01% 1412
2021
Q4 		– Sell
-1,670
Closed -$61K – 1659
2021
Q3 		$61K Buy
+1,670
New +$65.7K ﹤0.01% 1019

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jump Financial's RIGL Position: Q2 2026 in Review

Jump Financial opened a new position in Rigel Pharmaceuticals (RIGL) in Q2 2026: 6,100 shares worth $239K. The stake represents ﹤0.01% of the portfolio and ranks #1769 among its holdings. This is a return to the name: Jump Financial previously reported a position in RIGL as recently as Q2 2025.

Jump Financial first reported a position in RIGL in Q3 2021 and has held it in 6 quarters since. The position peaked at $505K in Q4 2024. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Jump Financial held 6,100 shares of Rigel Pharmaceuticals worth $239K as of Q2 2026.
  • Rigel Pharmaceuticals was a new Jump Financial position in Q2 2026.
  • Rigel Pharmaceuticals made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1769 holding.
  • Jump Financial first reported a position in Rigel Pharmaceuticals in Q3 2021 and has held it in 6 quarters since.
  • Jump Financial's Rigel Pharmaceuticals position peaked at $505K in Q4 2024.
  • 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.